GlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark
GlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark [...]
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics [...]
Roche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ plans as Eylea battle looms
Roche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ [...]
Eli Lilly, Innovent’s PD-1 in troubled waters as FDA review, oncology chief’s comments portend likely rejection
Eli Lilly, Innovent’s PD-1 in troubled waters as FDA review, [...]
As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus going away for ‘foreseeable future’
As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus [...]
Teva forks over $150M to settle Texas opioid suit
Teva forks over $150M to settle Texas opioid suit fkansteiner [...]
J&J, plowing ahead with talc bankruptcy strategy, faces investor push to pull product worldwide
J&J, plowing ahead with talc bankruptcy strategy, faces investor push [...]
Bayer poaches GlaxoSmithKline exec to lead expanding oncology business—including a blockbuster hopeful
Bayer poaches GlaxoSmithKline exec to lead expanding oncology business—including a [...]
Sanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for a rare blood disorder
Sanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally [...]
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody [...]